Xenetic Biosciences Analyst Price Targets - Benzinga

Xenetic Biosciences Inc

XBIONASDAQ

Trade with Public

Trade with Public

$2.08

0.020.97%

마지막 업데이트: Nov 3, 7:59 AM

개요 뉴스 실적 전망 이벤트목표가재무 심리 비교 주식 보고서

Xenetic Biosciences Analyst Price Targets - Benzinga

Xenetic Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xenetic Biosciences (XBIO).

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 9, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Mar 20, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Dec 5, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Nov 22, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—
Aug 20, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Neutral	—

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciences

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) with a Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciences

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) with a Neutral.

Benzinga Newsdesk

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Vandana Singh